Twin Health Company Profile

Background

Overview

Twin Health, founded in 2018, is a healthcare technology company specializing in AI-driven solutions for chronic metabolic diseases. The company has operations in both the United States and India. Its flagship product, the Whole Body Digital Twin™, offers personalized guidance on nutrition, sleep, activity, and breathing to help individuals reverse and prevent chronic metabolic conditions such as type 2 diabetes, obesity, and fatty liver disease.

Mission and Vision

Twin Health's mission is to empower individuals to reclaim their metabolic health and lead happier, healthier lives. The company envisions a future where personalized, AI-driven healthcare solutions are accessible to all, enabling the reversal and prevention of chronic metabolic diseases.

Industry Significance

Operating at the intersection of healthcare and technology, Twin Health is a pioneer in applying AI and digital twin technology to metabolic health. Its innovative approach has garnered recognition, including being named to CB Insights' 2021 Digital Health 150, a list of the most promising private digital health companies globally.

Key Strategic Focus

Core Objectives

Twin Health aims to provide personalized, data-driven solutions that address the root causes of chronic metabolic diseases, focusing on sustainable health improvements and medication reduction.

Areas of Specialization

The company specializes in metabolic health, particularly in reversing and preventing conditions like type 2 diabetes, obesity, and fatty liver disease.

Key Technologies Utilized

• Whole Body Digital Twin™: An AI-powered platform that creates a dynamic, digital representation of an individual's metabolism, integrating data from wearable sensors and self-reported preferences.

• IoT and Machine Learning: Technologies that enable continuous monitoring and personalized health guidance.

Primary Markets Targeted

Twin Health primarily targets self-insured employers, health plans, health systems, and risk-bearing providers committed to reversing and preventing chronic metabolic diseases. The company operates in both the U.S. and India.

Financials and Funding

Funding History

As of October 2021, Twin Health had raised a total of $198.5 million over three funding rounds, with the latest being a Series C round on October 7, 2021.

Recent Funding Rounds

• December 2023: Secured $50 million in a Series D funding round led by Temasek, aimed at enhancing technology and clinical service solutions to extend its footprint across the U.S.

Notable Investors

Investors include Temasek, Peak XV Partners, Sofina, and Iconiq.

Utilization of Capital

The funds are intended to enhance Twin Health's technology and clinical service solutions, aiming to extend its footprint across the U.S.

Pipeline Development

Key Pipeline Candidates

Twin Health's primary offering is the Whole Body Digital Twin™, which provides personalized guidance to individuals with chronic metabolic diseases.

Stages of Development

The Whole Body Digital Twin™ is currently in the deployment stage, with ongoing partnerships and implementations across various organizations.

Target Conditions

The technology targets chronic metabolic conditions such as type 2 diabetes, obesity, and fatty liver disease.

Anticipated Milestones

Twin Health continues to expand its partnerships and user base, aiming to demonstrate significant health improvements and cost savings for employers and health plans.

Technological Platform and Innovation

Proprietary Technologies

• Whole Body Digital Twin™: An AI-powered platform that creates a dynamic, digital representation of an individual's metabolism, integrating data from wearable sensors and self-reported preferences.

Significant Scientific Methods

• Digital Twin Technology: Utilizes AI to model and monitor an individual's unique metabolism, providing personalized health guidance.

• IoT Integration: Collects real-time data from wearable devices to inform health recommendations.

• Machine Learning Algorithms: Analyze complex health data to offer personalized insights and interventions.

Leadership Team

Executive Profiles

• Jahangir Mohammed: Founder & CEO. A serial inventor and entrepreneur, he previously founded Jasper Technologies, acquired by Cisco for $1.45 billion.

• Terry Poon: Co-Founder, EVP, & CTO. Led engineering at Jasper Technologies and holds a Master's from MIT.

• Maluk Mohamed: Co-Founder & VP Research. Leads global trend studies and operations in India; holds a PhD from IIT Madras.

• Lisa Shah, MD: EVP & Chief Medical Officer. Oversees U.S. clinical operations and innovation; former CMO at Advantia Health.

• Tom Samuelson: Chief Financial Officer. Manages global financial strategy; previously led financial planning at Precigen.

• Jen Bealer: Chief Legal Officer. Former EVP and General Counsel at Progyny; holds a J.D. from the University of Pennsylvania.

• Adam Johnson: Chief Growth & Strategy Officer. Focuses on growth and retention efforts; 21 years in the healthcare industry.

• Bruce Dunlevie: Founder/General Partner, Benchmark Capital. Over 30 years in venture capital; early investor in companies like eBay and Twitter.

• Kevin Johnson: Former CEO/President, Starbucks. Led Starbucks' global operations; former president and COO of Juniper Networks.

• Caroline Xie: General Partner, ICONIQ. Invests in software, healthcare, and internet companies; former financial analyst at Morgan Stanley.

• Ravi Lambah: Head, Strategic Initiatives, Temasek. Over 30 years in investment and banking; head of Temasek's Telecom, Media, and Technology group.

• Francine R. Kaufman, MD: Chief Medical Officer at Senseonics; former president of the American Diabetes Association.

• Jeffrey I. Mechanick, MD: Professor of Medicine, Mount Sinai; expert in endocrinology and metabolism.

• Elbert Huang, MD: Director, Center for Chronic Disease Research and Policy, University of Chicago; expert in diabetes and health economics.

• Ambrish Mithal, MD: Chairman and Head of Endocrinology & Diabetes, Max Healthcare India; recognized for contributions to diabetes care.

• Shashank Joshi, MD: President, Indian Academy of Diabetes; globally recognized endocrinologist.

• Patrick Conway, MD, MSc: CEO of Care Solutions, Optum; former president and CEO of Blue Cross and Blue Shield of North Carolina.

• Michelle Harika, PharmD: Principal at Blackstone and Chief Clinical Officer for Equity Healthcare; former clinical program leader at Anthem.

• Ronald A. Williams: Chairman and CEO, RW2 Enterprises; former chairman and CEO of Aetna Inc.

Competitor Profile

Market Insights and Dynamics

The digital twin technology in healthcare is a rapidly evolving sector, with companies like Dassault Systèmes and Brainlab leading in treatment planning and patient monitoring. Twin Health holds a significant position in this market, focusing on personalized metabolic health solutions.

Competitor Analysis

• Dassault Systèmes: Leads in treatment planning and patient monitoring with products like Emma Twin and Meditwin.

• Brainlab: Specializes in digitizing medical workflows, offering solutions for enhanced patient management across healthcare providers.